Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

904 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
Kharitonova T, Ahmed N, Thorén M, Wardlaw JM, von Kummer R, Glahn J, Wahlgren N. Kharitonova T, et al. Among authors: wardlaw jm. Cerebrovasc Dis. 2009;27(1):51-9. doi: 10.1159/000172634. Epub 2008 Nov 15. Cerebrovasc Dis. 2009. PMID: 19018138
Availability of CT and MR for assessing patients with acute stroke.
Kane I, Whiteley WN, Sandercock PA, Wardlaw JM. Kane I, et al. Among authors: wardlaw jm. Cerebrovasc Dis. 2008;25(4):375-7. doi: 10.1159/000120688. Epub 2008 Mar 14. Cerebrovasc Dis. 2008. PMID: 18340104 Free article. No abstract available.
Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, Wahlgren N; SITS investigators. Kharitonova T, et al. Among authors: wardlaw jm. J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):273-8. doi: 10.1136/jnnp.2008.150185. Epub 2008 Oct 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 18931005
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Among authors: wardlaw jm. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
904 results